Market News & Trends
Celsus Therapeutics Buys Volution Immuno Pharma; Combined Company to be Renamed
Celsus Therapeutics and Volution Immuno Pharmaceuticals SA recently announced that they have entered into a Definitive Exchange Agreement, pursuant to which privately-held Volution Immuno Pharmaceuticals…
Allegro Ophthalmics Announces Positive Topline Results From Phase II Trial
Allegro Ophthalmics, LLC, recently announced that the Phase II clinical trial of Luminate® (ALG-1001) in patients with vitreomacular traction (VMT) or vitreomacular adhesion (VMA) met…
Genentech’s Investigational Immunotherapy Atezolizumab Shrank Tumors in Pivotal Study
Genentech, a member of the Roche Group recently announced that in the IMvigor 210 study, the investigational cancer immunotherapy atezolizumab (MPDL3280A; anti-PDL1) shrank tumors (objective…
Lonza to Expand Availability of 3D Cell Culture System
Lonza has announced that it has reached an exclusive agreement with TAP Biosystems, part of the Stedim Biotech Group, to distribute the company’s RAFT™ (Real…
DPT Enhances Flexibility & Efficiencies at San Antonio Facility
DPT Laboratories, a contract development and manufacturing organization (CDMO) specializing in semi-solids and liquids, has implemented a new order execution strategy that will enhance operations…
Catalent Biologics Adds New Technology Platform
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that…
Foster Polymer Copolymer for Medical Mandrels & Release Films
Foster Polymer Distribution, a business unit of Foster Corporation specializing in the distribution of medical polymers and additives, announces their official partnership with Mitsui Chemicals…
Celgene & Juno Announce 10-Year Collaboration to Advance Potentially Groundbreaking Immunotherapies
Celgene Corporation (Nasdaq:CELG) and Juno Therapeutics, Inc. (Nasdaq:JUNO) announced today a global collaboration for the development and commercialization of immunotherapies. The two companies will leverage…
Leti & Eight Partners in BIOCAPAN Project Working On Diabetes Treatment to Replace Injections
An international research consortium coordinated by CEA-Leti announced the launch of BIOCAPAN, a research project funded by the European Commission aiming at developing an innovative…
Transdermal Specialties Announces Success of Insulin Patch Clinical Trial
In June, 2015 TSI began the HPT-6B.3 clinical trial with 12 type-2 diabetic volunteers, both male and female subjects, who were subject to a 24…